ExecEdge – Page 30

VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC

By Karen Roman VERAXA Biotech AG said it has a securities purchase agreement with an institutional investor for $27.5 million, separate to a $50 million...

VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC

World Gym & HYROX Partner for Taiwan & Thailand Expansion

SpaceX & Beyond – Public & Private Capital Markets Assessment: 2nd Princeton CorpGov Forum

Alpha Compute: $21 Million NTM Sales Outlook Shows Scale-Up Potential – Quarterly Update Report